Zerai Manna
National Institute of Arthritis and Musculoskeletal and Skin Diseases
ORCID: 0000-0003-1318-2213Also affiliated with Malaysian Society of Nephrology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 11 papers. Top paper: “Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus”.
Sarthak Gupta, Michael A. Davis, Elaine Poncio, Yenealem Temesgen‐Oyelakin, Philip M. Carlucci +34 more
Yenealem Temesgen‐Oyelakin, Michael A. Davis, Jun Chu, Elaine Poncio, Mohammad Naqi +27 more
Shuichiro Nakabo, Kan Jiang, Carmelo Carmona‐Rivera, Wanxia Li Tsai, Dillon Claybaugh +17 more
Ranjitha Gaddipati, Emily L. Ongstad, Nicholas Bhagroo, Ling–Ling An, Jingya Wang +13 more
Carmelo Carmona‐Rivera, Victoria Hoffmann, Kan Jiang, Zerai Manna, Davide Randazzo +4 more
Binod Regmi, Carmelo Carmona‐Rivera, Yudong Liu, Xiantao Wang, Philip M. Carlucci +7 more
Angel Aponte, Davide Randazzo, Paniz Rezvan Sangsari, Alexander Wood, Jack Bibby +17 more
Dillon Claybaugh, Eduardo Patino Martinez, Yenealem Temesgen‐Oyelakin, Elaine Poncio, Jun Chu +32 more
Li Feng, Marquis Chapman, Sarthak Gupta, Anam Ahmad, Adam D. Munday +15 more
Donavon Sandoval-Heglund, Norio Hanata, Stephen R. Brooks, Victoria Hoffmann, Mingzeng Zhang +8 more
Shuichiro Nakabo, Kan Jiang, Carmelo Carmona‐Rivera, Wanxia Li Tsai, Dillon Claybaugh +17 more